Record

Minimum publication package

case_id
CW-2026-03-PHARMA-POLICY
industry
Pharmaceuticals
scope
Owned public pages that republish policy, indication-adjacent, and usage/labeling excerpts across product hubs, HCP/patient FAQs, and downloadable resources.
approved_by
NRLC editorial gate
approved_at
2026-09-12
release_id
unavailable — withheld
deployed_at
unavailable — withheld

Admission chain

Seven separate records

  1. 01

    Observed condition

    Multiple owned URLs presented overlapping policy and usage passages with different revision dates and conflicting quantitative statements. Structured metadata (where present) did not identify the labeling revision that authorized the text. Older PDF and FAQ mirrors remained indexable beside newer hubs.

  2. 02

    Evidence

    unavailable — withheld: URL inventory of conflicting policy/usage passages unavailable — withheld: labeling / SPL revision identifiers used as SoT unavailable — withheld: crawler extracts showing conflicting spans on owned hosts

  3. 03

    Decision

    Treat labeled content (SPL-aligned source-of-truth) as the only authority for policy and usage excerpts on owned sites. Every public excerpt must cite a revision id, expire or noindex superseded mirrors, and render from governed fragments rather than hand-edited HTML forks.

  4. 04

    Intervention

    Mapped each public excerpt to a labeling revision id; rebuilt hubs to inject governed fragments; applied retirement rules (410/301/noindex) to superseded FAQs and PDFs; added visible “label revision / last reviewed” fields next to usage and policy blocks; blocked unpublished draft fragments from production templates.

  5. 05

    Verification

    For a frozen set of indication/policy queries against owned URLs, confirm only current revision text is returned in HTML; confirm retired mirrors are non-indexable or redirected; confirm on-page revision identifiers match the SoT register.

    unavailable — withheld: pre/post URL status and robots/meta outcomes unavailable — withheld: revision-id reconciliation for sampled excerpts

  6. 06

    Result

    On the verified URL set, conflicting superseded passages were retired or redirected, and remaining public excerpts carried matching labeling revision identifiers from the source-of-truth register.

    Technical verification only — no efficacy, safety, prescribing, traffic, or citation-rate claims are published.

  7. 07

    Limitations

    This page is not medical advice and does not reproduce labeled prescribing information. Client identity, product names, and raw artifacts are withheld. Regulatory submission systems and third-party health sites were out of scope. No claim that external answer engines dropped prior citations of retired mirrors. FDA SPL and Drugs@FDA references document industry data standards; they are not evidence of a specific client’s submission package.

Decision record

Alternatives considered

  • Add more schema.org Drug markup without fixing copy forks — rejected; structured types cannot heal contradictory text spans
  • robots-disallow all FAQs — rejected; overblocks useful navigation and does not repair canonical hubs
  • Leave PDFs live as “archive” without labels — rejected; archives remained the retrieved spans

Methods used

Inherited public methodology

  • Source-of-truth governance for regulated excerpts
  • Index hygiene for superseded mirrors
  • Decision traces separating observation from outcome claims
Decision TracesSeparates observation, evidence, interpretation, decision, action, and verification. Enterprise SchemaLarge-scale JSON-LD and source-of-truth records.